Middle East and Africa Anti-Infective Agents Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa Anti-Infective Agents Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa Anti-Infective Agents Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Prevalence of Targeted Diseases

5.2 Market Opportunities

5.2.1 Rising Government Support for Research Activities

5.3 Future Trends

5.3.1 Development of New Anti-infective Agents

5.4 Impact of Drivers and Restraints

6. Middle East and Africa Anti-Infective Agents Market Regional Analysis

6.1 Middle East and Africa Anti-Infective Agents Market Overview

6.2 Middle East and Africa Anti-Infective Agents Market Revenue 2020-2028 (US$ Million)

6.3 Middle East and Africa Anti-Infective Agents Market Forecast Analysis

7. Middle East and Africa Anti-Infective Agents Market Analysis – by Type

7.1 Anti-Viral

7.1.1 Overview
7.1.2 Anti-Viral: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Anti-Bacterial

7.2.1 Overview
7.2.2 Anti-Bacterial: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Anti-Fungal

7.3.1 Overview
7.3.2 Anti-Fungal: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Anti-Infective Agents Market Analysis – by Range

8.1 Narrow Spectrum and Broad Spectrum

8.1.1 Overview
8.1.2 Narrow Spectrum and Broad Spectrum: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East and Africa Anti-Infective Agents Market Analysis – by Route of Administration

9.1 IV

9.1.1 Overview
9.1.2 Narrow Spectrum and Broad Spectrum: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Oral

9.2.1 Overview
9.2.2 Narrow Spectrum and Broad Spectrum: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Topical

9.3.1 Overview
9.3.2 Narrow Spectrum and Broad Spectrum: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East and Africa Anti-Infective Agents Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Anti-Infective Agents Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa Anti-Infective Agents Market Breakdown, by Type
10.1.1.1.2 South Africa: Middle East and Africa Anti-Infective Agents Market Breakdown, by Range
10.1.1.1.3 South Africa: Middle East and Africa Anti-Infective Agents Market Breakdown, by Route of Administration

10.1.1.2 Saudi Arabia: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa Anti-Infective Agents Market Breakdown, by Type
10.1.1.2.2 Saudi Arabia: Middle East and Africa Anti-Infective Agents Market Breakdown, by Range
10.1.1.2.3 Saudi Arabia: Middle East and Africa Anti-Infective Agents Market Breakdown, by Route of Administration

10.1.1.3 UAE: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa Anti-Infective Agents Market Breakdown, by Type
10.1.1.3.2 UAE: Middle East and Africa Anti-Infective Agents Market Breakdown, by Range
10.1.1.3.3 UAE: Middle East and Africa Anti-Infective Agents Market Breakdown, by Route of Administration

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Anti-Infective Agents Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Anti-Infective Agents Market Breakdown, by Type
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Anti-Infective Agents Market Breakdown, by Range
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Anti-Infective Agents Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa Anti-Infective Agents Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Allergan Plc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Astellas Pharma Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bayer AG

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Boehringer Ingelheim International GmbH

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Bristol-Myers Squibb Company

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 F. Hoffmann-La Roche Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Gilead Sciences, Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 GlaxoSmithKline plc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Merck & Co., Inc.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Novartis AG

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights